Clinical trial
Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
NCT02909751 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
- Lead sponsor
- Vejle Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 14, 2016
- Completion date
- January 21, 2019
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer